Overall, these findings suggest that MAC increases the anti-cancer activity of 5-FU by suppressing the phosphorylation of Akt/mTOR/p70S6K, as well as nuclear β-catenin expression in CRC cells. The gene discussed is RPS6KB1; the disease is cancer.